Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review

@article{Cholongitas2014MammalianTO,
  title={Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review},
  author={E. Cholongitas and Chrysanthi Mamou and K. Rodr{\'i}guez-Castro and P. Burra},
  journal={Transplant International},
  year={2014},
  volume={27}
}
Calcineurin inhibitors (CNIs) have been associated in a dose‐dependent fashion with an increased risk of post‐transplant hepatocellular carcinoma (HCC) recurrence. The mammalian target of rapamycin inhibitors (mTORi) (sirolimus/everolimus) might represent an alternative immunosuppressive regimen with antineoplastic effect. In the present systematic review, the association between mTORi and HCC recurrence after liver transplantation (LT) was evaluated and compared against that of CNIs‐treated… Expand
114 Citations
Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story?
  • N. Mehta, J. Roberts, F. Yao
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2016
  • 6
Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant
  • A. Mancuso, G. Perricone
  • Medicine
  • Transplant international : official journal of the European Society for Organ Transplantation
  • 2015
  • 10
Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
  • D. Jung, E. Tak, +12 authors S. Lee
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2018
  • 9
Reply to: Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant
  • E. Cholongitas, P. Burra
  • Medicine
  • Transplant international : official journal of the European Society for Organ Transplantation
  • 2015
  • 1
Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
  • 34
  • PDF
Use of everolimus in liver transplantation: The French experience.
  • 16
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 89 REFERENCES
Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
  • 91
  • Highly Influential
Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation
  • S. Chinnakotla, G. Davis, +7 authors G. Klintmalm
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2009
  • 118
Effects of rapamycin in liver transplantation.
  • 14
  • Highly Influential
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression
  • M. Vivarelli, A. Cucchetti, +4 authors A. Pinna
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2005
  • 179
A Randomized, Controlled Study to Assess the Conversion From Calcineurin‐Inhibitors to Everolimus After Liver Transplantation—PROTECT
  • L. Fischer, J. Klempnauer, +23 authors H. Schlitt
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2012
  • 134
  • Highly Influential
Sirolimus‐based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta‐analysis
  • W. Liang, Dong-ping Wang, +5 authors X. He
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2012
  • 126
  • Highly Influential
...
1
2
3
4
5
...